Company Number: NI695189

Analysis Date: 2025-07-20 14:48 UTC

Financial Health Assessment Report for FINE FOCUS LIMITED
Assessment Date: Post 31 March 2025 financial year end

---

1. Financial Health Score: B+

Explanation:
FINE FOCUS LIMITED exhibits strong liquidity and growing net asset value, which are positive signs of financial wellness for a young micro-entity. The company’s net current assets and net assets have shown a marked increase in the latest year, indicating healthy operational cash flow and prudent management of short-term obligations. However, the company is still in its infancy (incorporated in 2023), and the scale of operations remains small, limiting the robustness of financial indicators. The absence of detailed profitability data and reliance on micro-entity reporting standards suggest cautious optimism.

---

2. Key Vital Signs: Critical Metrics and Interpretation

Metric	2025 Value (£)	2024 Value (£)	Interpretation
Current Assets	74,237	21,164	Strong increase indicates improved liquidity and available cash or receivables to meet short term needs.
Current Liabilities	12,893	4,382	Higher liabilities but well covered by current assets, maintaining healthy working capital.
Net Current Assets	61,344	16,782	Positive working capital “buffer” shows the company can comfortably cover short-term debts.
Net Assets / Shareholders Funds	60,564	16,782	Growth in equity suggests retained earnings or capital injections; solid foundation for expansion.
Average Employees	2	2	Small workforce consistent with micro-entity status; manageable cost base.
Share Capital	100	100	Minimal capital base typical for micro-entity; equity growth likely from accumulated earnings.

Additional Observations:

• Company status is active with no overdue filings, indicating good compliance discipline—an important sign of operational health.
• Business sector: Specialist medical practice (SIC 86220), which typically requires steady cash flow and compliance with regulatory standards.
• Directors and persons with significant control have clear ownership and governance roles, enhancing accountability.

---

3. Diagnosis: Financial Condition Overview

FINE FOCUS LIMITED is in the early stages of its business lifecycle but shows healthy financial “vital signs.” The substantial growth in net current assets and net assets over one year is analogous to a patient recovering well after initial treatment, reflecting improved cash flow and prudent management of resources. The company maintains a strong liquidity position, with current assets exceeding current liabilities by a large margin, indicating no immediate risk of financial distress.

The micro-entity size and exemption from audit suggest simplified reporting, which limits detailed insight into profitability and cash flow dynamics. However, the consistency in employee numbers and stable share capital, combined with increased net assets, point to retained earnings or additional investment, which is a positive “symptom” of growth.

No red flags such as overdue filings, director disqualifications, or significant financial stress indicators are present. The company’s governance appears solid with directors holding clear control and responsibility.

---

4. Recommendations: Actions to Improve Financial Wellness

1. Maintain Strong Cash Flow Management:
   Continue to monitor liquidity closely to ensure that working capital remains healthy as the business grows, especially given the micro-entity scale where cash flow shocks can be critical.

2. Enhance Financial Reporting Over Time:
   As the company matures, consider moving beyond micro-entity accounting provisions to provide deeper insights into profitability and operational efficiency, which can support strategic decision-making.

3. Diversify Capital Base:
   With only £100 in share capital, explore options for additional equity funding or reserves to strengthen the balance sheet and support future expansion or investment in specialist equipment.

4. Strategic Planning for Growth:
   Given the specialist medical practice sector, invest in compliance, staff training, and technology to sustain steady revenue growth and meet regulatory demands.

5. Risk Management:
   Proactively assess and manage risks related to client concentration, regulatory changes, and market conditions to avoid financial “symptoms” of distress.

---